Drug information for LARODOPA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
100MG
Discontinued
LEVODOPA
Levodopa
ROCHE
16912
CAPSULE; ORAL
250MG
Discontinued
LEVODOPA
Levodopa
ROCHE
"
CAPSULE; ORAL
500MG
Discontinued
LEVODOPA
Levodopa
ROCHE
"
TABLET; ORAL
100MG
Discontinued
LEVODOPA
Levodopa
ROCHE
"
TABLET; ORAL
250MG
Discontinued
LEVODOPA
Levodopa
ROCHE
"
TABLET; ORAL
500MG
Discontinued
LEVODOPA
Levodopa
ROCHE
"
Drug Adverse Effects information for LARODOPA
Role code
Indications
Reaction
# Reports
C
PARKINSON'S DISEASE
BLOOD CREATINE PHOSPHOKINASE INCREASED
2
C
PARKINSON'S DISEASE
BLOOD CREATININE INCREASED
1
C
PARKINSON'S DISEASE
BLOOD UREA INCREASED
1
C
PARKINSON'S DISEASE
C-REACTIVE PROTEIN INCREASED
1
C
PARKINSON'S DISEASE
DYSKINESIA
1
C
PARKINSON'S DISEASE
NEUROLEPTIC MALIGNANT SYNDROME
2
C
PARKINSON'S DISEASE
PYREXIA
2
C
PARKINSON'S DISEASE
RENAL FAILURE
1
C
PARKINSON'S DISEASE
SOMNOLENCE
1
C
PARKINSON'S DISEASE
WHITE BLOOD CELL COUNT INCREASED
1
Ads by Google